The role of inflammatory biomarkers in CHD-associated pulmonary hypertension in children

Publisher： Cambridge University Press

E-ISSN： 1467-1107|27|2|255-260

ISSN： 1047-9511

Source： Cardiology in the Young, Vol.27, Iss.2, 2016-06, pp. : 255-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Stress and inflammatory biomarkers and symptoms are associated with bioimpedance measures

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 2, 2015-02 ,pp. : 126-134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of inhaled iloprost in children with pulmonary hypertension

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 4, 2015-04 ,pp. : 370-379

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Sarcoidosis-Associated Pulmonary Hypertension with Bosentan

By  

Respiration, Vol. 75, Iss. 2, 2005-11 ,pp. : 211-214

Karger

Access to resources Recommend Favorite

Biomarkers of pulmonary hypertension after preterm birth: The IMPROV study

By  

PEDIATRIC PULMONOLOGY, Vol. 53, Iss. 2, 2018-02 ,pp. : 124-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers

By  

PEDIATRIC PULMONOLOGY, Vol. 53, Iss. 3, 2018-03 ,pp. : 302-309

John Wiley & Sons Inc

Access to resources Recommend Favorite